Rapid Micro Biosystems, Inc. is a life sciences technology company providing mission critical automation solutions to facilitate the manufacturing and release of healthcare products, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company's flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control, testing workflows used in pharmaceutical manufacturing operations. It offers four specific applications for testing of microbial contamination: Environmental Monitoring, which tests the manufacturing environment, including circulating air, exposed surfaces, and personnel; Water, which tests any purified water used at any stage of the drug production process, including water for injection; In-Process Bioburden, which tests raw materials, drug substance and in-process product, and Sterility Release offering final testing of finished product to ensure sterility before the product is released for commercial sale.
Símbolo de cotizaciónRPID
Nombre de la empresaRapid Micro Biosystems Inc
Fecha de salida a bolsaJul 15, 2021
Director ejecutivoMr. Robert (Rob) Spignesi
Número de empleados163
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 15
Dirección25 Hartwell Avenue
CiudadLEXINGTON
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal02421
Teléfono19783493200
Sitio Webhttps://www.rapidmicrobio.com/
Símbolo de cotizaciónRPID
Fecha de salida a bolsaJul 15, 2021
Director ejecutivoMr. Robert (Rob) Spignesi
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos